Clinical Trial: Comparative Study of MRI and TU in Identifying Clinically Significant Prostate Cancer Among Ethnic Groups

U.S., July 3 -- ClinicalTrials.gov registry received information related to the study (NCT07048613) titled 'Comparative Study of MRI and TU in Identifying Clinically Significant Prostate Cancer Among Ethnic Groups' on June 24.

Brief Summary: This study is designed to compare the diagnostic accuracy of Magnetic Resonance Imaging (MRI) and Transrectal Ultrasound (TRUS) in detecting clinically significant prostate cancer, using histopathology (biopsy results) as the gold standard. Prostate cancer is a leading cause of cancer-related morbidity among men globally, and its detection often varies across ethnic groups due to genetic, environmental, and healthcare access factors. This research aims to evaluate how MRI and TRUS perform across divers...